Where this fits: Patients increasingly encounter commercial claims about biomarkers, genetic panels, and brain-based diagnostics for bipolar disorder. This lesson evaluates what the current evidence actually supports, separating the few established clinical applications from the many investigational findings, and providing the language to counsel patients accurately about each technology.